Hoese & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78K Hold
65
0.05% 91
2026
Q1
$59.8K Hold
65
0.04% 83
2025
Q4
$69.9K Hold
65
0.05% 77
2025
Q3
$49.6K Hold
65
0.04% 85
2025
Q2
$50.7K Hold
65
0.04% 93
2025
Q1
$53.7K Hold
65
0.05% 65
2024
Q4
$50.2K Hold
65
0.04% 71
2024
Q3
$57.6K Hold
65
0.05% 68
2024
Q2
$53.3K Buy
65
+15
+30% +$12K 0.05% 61
2024
Q1
$37.7K Hold
50
0.03% 75
2023
Q4
$29.6K Hold
50
0.03% 80
2023
Q3
$26.9K Hold
50
0.03% 87
2023
Q2
$23.4K Hold
50
0.02% 98
2023
Q1
$15.6K Hold
50
0.02% 105
2022
Q4
$19K Hold
50
0.02% 106
2022
Q3
$16K Hold
50
0.02% 113
2022
Q2
$16K Hold
50
0.02% 115
2022
Q1
$14K Hold
50
0.01% 130
2021
Q4
$14K Buy
+50
New +$12.7K 0.01% 132
2021
Q2
Sell
-240
Closed -$45K 208
2021
Q1
$45K Buy
+240
New +$46.9K 0.06% 77

Other funds holding LLY

Hoese & Co's LLY Position: Q2 2026 in Review

Hoese & Co held its Eli Lilly (LLY) position steady in Q2 2026 at 65 shares worth $78K. The position accounts for 0.05% of the portfolio, ranked #91.

Hoese & Co first reported a position in LLY in Q1 2021 and has held it in 20 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hoese & Co held 65 shares of Eli Lilly worth $78K as of Q2 2026.
  • Hoese & Co left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.05% of Hoese & Co's portfolio in Q2 2026, its #91 holding.
  • Hoese & Co first reported a position in Eli Lilly in Q1 2021 and has held it in 20 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hoese & Co's 13F filing for Q2 2026, filed 14 Jul 2026.